Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect
- 31 March 2005
- journal article
- Published by Elsevier in Human Immunology
- Vol. 66 (3) , 231-240
- https://doi.org/10.1016/j.humimm.2004.12.004
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritisClinical and Experimental Immunology, 2003
- Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxisClinical and Experimental Immunology, 2002
- The liver as a site of T-cell apoptosis: graveyard, or killing field?Immunological Reviews, 2000
- Bone Marrow NK1.1− and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host DiseaseThe Journal of Experimental Medicine, 1999
- TCR αβ+ CD4− CD8− T cells differentiate extrathymically in an lck‐independent manner and participate in early response against Listeria monocytogenes infection through interferon‐γ productionImmunology, 1997
- PREDICTION BY A MODIFIED MIXED LEUKOCYTE REACTION ASSAY OF GRAFT-VERSUS-HOST DISEASE AND GRAFT REJECTION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1994
- Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple SclerosisScience, 1993
- T CELL SUBSETS AND GRAFT-VERSUS-HOST DISEASETransplantation, 1987
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979